Mirtazapina Flas Bluefish (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine, and by antagonizing postsynaptic 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic activity while reducing certain serotonin‑related side effects.

The appropriate dose of mirtazapine is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerability. Dosage adjustments are made according to professional guidelines and patient needs.

Safety data for mirtazapine in pregnancy and lactation are limited. Clinicians should weigh potential benefits against possible risks and consider alternative treatments when treating pregnant or nursing individuals.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike SSRIs, which primarily increase serotonin reuptake inhibition, mirtazapine enhances both norepinephrine and serotonin release through its unique receptor profile. It often causes more sedation and weight gain but may be preferred when patients experience insomnia or need a rapid antidepressant effect.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Mirtazapina Flas Bluefish is taken orally, usually once daily in the evening, as directed by the prescribing healthcare professional. Swallow the tablet whole with water; do not crush or split unless specifically instructed.

Serious risks include agranulocytosis, severe neutropenia, hepatotoxicity, seizures, and the emergence or worsening of suicidal thoughts, especially during early treatment or dose changes. Prompt medical attention is required if any of these occur.

Mirtazapine is contraindicated in individuals with known hypersensitivity to the drug, those currently taking monoamine oxidase inhibitors, or patients with severe hepatic impairment where the risk outweighs benefit. Caution is also advised for patients with a history of bipolar disorder or uncontrolled seizures.